688513 苑东生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.8698.97710.41010.59612.759
总资产报酬率 ROA (%)2.2327.1208.5118.76110.129
投入资产回报率 ROIC (%)2.5758.2479.94610.28312.486

边际利润分析
销售毛利率 (%)79.82380.01383.25585.99088.613
营业利润率 (%)25.46821.63922.26623.86821.563
息税前利润/营业总收入 (%)25.12720.63221.50723.75521.253
净利润/营业总收入 (%)23.81320.28221.06122.72219.325

收益指标分析
经营活动净收益/利润总额(%)70.85668.39065.41456.31063.260
价值变动净收益/利润总额(%)7.85610.54310.62717.0274.788
营业外收支净额/利润总额(%)-0.162-0.0400.5191.1200.128

偿债能力分析
流动比率 (X)2.8562.8483.2284.1144.916
速动比率 (X)2.5942.6052.9623.8744.698
资产负债率 (%)22.17522.21118.99217.42517.212
带息债务/全部投入资本 (%)8.6118.9493.8781.0950.286
股东权益/带息债务 (%)1,044.6161,001.0032,435.0878,836.86234,003.444
股东权益/负债合计 (%)350.962350.236426.547473.874480.992
利息保障倍数 (X)-83.791-20.659-24.583-62.008-62.805

营运能力分析
应收账款周转天数 (天)40.22141.42938.34841.12746.926
存货周转天数 (天)237.562243.347224.584235.768247.656